Aiding and ABT'ing treatment for glioblastoma

Commentary to: ABT-510, a Modified Type 1 Repeat Peptide of Thrombospondin, Inhibits Malignant Glioma Growth In Vivo by Inhibiting Angiogenesis Joshua C. Anderson, J. Robert Grammer, Wenquan Wang, L. Burton Nabors, Jack Henkin, Jerry E. Stewart Jr. and Candece L. Gladson Volume 6, Issue 3; 454-462

Saved in:
Bibliographic Details
Published inCancer biology & therapy Vol. 6; no. 5; pp. 802 - 804
Main Authors Chung, Elaine Y., Dews, Michael, Maity, Amit, Thomas-Tikhonenko, Andrei
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.05.2007
Subjects
Antineoplastic Agents - therapeutic use
Binding
Biology
Bioscience
Brain Neoplasms - drug therapy
Calcium
Cancer
Cell
Cycle
Glioblastoma - drug therapy
Humans
Landes
Organogenesis
Proteins
Online AccessGet full text

Cover

More Information
Summary:Commentary to: ABT-510, a Modified Type 1 Repeat Peptide of Thrombospondin, Inhibits Malignant Glioma Growth In Vivo by Inhibiting Angiogenesis Joshua C. Anderson, J. Robert Grammer, Wenquan Wang, L. Burton Nabors, Jack Henkin, Jerry E. Stewart Jr. and Candece L. Gladson Volume 6, Issue 3; 454-462
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1538-4047
1555-8576
DOI:10.4161/cbt.6.5.4431